Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.11%
SPX
+0.38%
IXIC
+0.72%
FTSE
+0.26%
N225
-0.88%
AXJO
-1.82%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
6.08M
Dividend Yield
0.00%
P/E Ratio
-3.06
EPS
-10.25
Revenue
122.00K
Avg. Volume
3.35M

Recently from Cashu

publisher logo
Cashu

VivoSim Labs Partners with NIO for Innovative Electric Vehicle Insurance Solutions

4 days ago
publisher logo
Cashu

VivoSim Labs Partners with NIO to Innovate Auto Insurance for Electric Vehicles

5 days ago
publisher logo
Cashu

VivoSim Labs Monitors NIO Inc.'s Q1 Results for EV Market Insights

3 months ago

About

What does VIVS do?
Organovo Holdings, based in San Diego, focuses on developing bioprinted human tissues for inflammatory bowel disease, employing 20 staff since its IPO in 2013. The company utilizes proprietary technology and its Mosaic division for research and development of 3D tissues.
Sector
💻 Health Care
IPO
CEO
Employees
13
Headquarters
California, USA
Website
http://www.organovo.com
Stocks
Health Care
vivs
VivoSim Labs
NASDAQ: VIVS
-0.08 (0.00%)
2.36
USD
At close at Sep 03, 13:26 UTC
Summary
News
Signals
Benchmarks
Financials